The COVID-19 pandemic is an unrivaled scientific and global health challenge. As a company with a long legacy of research in infectious diseases, we have a responsibility to help.
We remain committed
We’ve been committed to trying to develop an effective response to the COVID-19 pandemic since it was first recognized. We know that success will require global collaboration among countries and companies and more. That’s why we’ve entered a partnership to support the manufacturing and supply of Johnson & Johnson’s COVID-19 vaccine and are working on advancing our therapeutic candidate.
Expanding manufacturing capacity and supply of COVID-19 medicines and vaccines
In March 2021, we announced an agreement with BARDA to adapt and make available a number of the company’s manufacturing facilities for production of COVID-19 vaccines and medicines. Additionally, we announced agreements with Johnson & Johnson to support manufacturing and supply of Johnson & Johnson’s SARS-CoV-2/COVID-19 vaccine.
Stories that inspire our work
Our work in the fight against COVID-19 reaches across all corners of our company, our personal lives and our communities, where many of our medically trained employees have volunteered their time.
I’m a Black woman and stroke survivor – here’s why I joined a COVID-19 vaccine trial
Kieta D. Mutepfa is a participant in the Phase 3 COVID-19 clinical trials. She also uses her voice to create an impact on the world
Businesses have a role to play in building vaccine trust. Here’s why
Employers are trusted messengers of credible information on vaccines